4//SEC Filing
Ludwig Jeffrey Jerome 4
Accession 0001437749-22-006268
CIK 0001401667other
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 1:37 PM ET
Size
7.1 KB
Accession
0001437749-22-006268
Insider Transaction Report
Form 4
Ludwig Jeffrey Jerome
Chief Commercial Officer
Transactions
- Award
Common Stock
2022-03-03+39,118→ 70,460 total - Award
Stock Option (Right to Buy)
2022-03-03+55,882→ 55,882 totalExercise: $2.33Exp: 2032-03-02→ Common Stock (55,882 underlying)
Footnotes (2)
- [F1]Subject to the Grantee's continued service with the Company through the applicable vesting date, the Restricted Stock Units shall vest with respect to one-fourth (1/4th) of the Restricted Stock Units on each of July 1, 2022, January 1, 2023, July 1, 2023 and January 1, 2024.
- [F2]Subject to the Optionee's continued service with the Company through the applicable vesting date, the Option shall vest and become exercisable with respect to one-fourth (1/4th) of the Shares subject thereto on each of July 1, 2022, January 1, 2023, July 1, 2023 and January 1, 2024.
Documents
Issuer
PUMA BIOTECHNOLOGY, INC.
CIK 0001401667
Entity typeother
Related Parties
1- filerCIK 0001807133
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 1:37 PM ET
- Size
- 7.1 KB